American Century Companies’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,275,067
| Closed | -$127M | – | 1606 |
|
|
2019
Q3 | $127M | Sell |
1,275,067
-1,442,943
| -53% | -$137M | 0.13% | 208 |
|
|
2019
Q2 | $251M | Sell |
2,718,010
-1,147,712
| -30% | -$109M | 0.25% | 115 |
|
|
2019
Q1 | $365M | Buy |
3,865,722
+172,466
| +5% | +$15.1M | 0.37% | 64 |
|
|
2018
Q4 | $237M | Sell |
3,693,256
-180,811
| -5% | -$13.3M | 0.27% | 99 |
|
|
2018
Q3 | $347M | Buy |
3,874,067
+124,912
| +3% | +$11M | 0.34% | 74 |
|
|
2018
Q2 | $298M | Sell |
3,749,155
-574,623
| -13% | -$47.7M | 0.3% | 87 |
|
|
2018
Q1 | $386M | Buy |
4,323,778
+258,561
| +6% | +$24.8M | 0.39% | 64 |
|
|
2017
Q4 | $424M | Sell |
4,065,217
-2,426,433
| -37% | -$274M | 0.42% | 50 |
|
|
2017
Q3 | $947M | Buy |
6,491,650
+9,517
| +0.1% | +$1.3M | 0.96% | 11 |
|
|
2017
Q2 | $842M | Sell |
6,482,133
-81,658
| -1% | -$10M | 0.87% | 11 |
|
|
2017
Q1 | $817M | Buy |
6,563,791
+276,089
| +4% | +$33M | 0.85% | 10 |
|
|
2016
Q4 | $728M | Buy |
6,287,702
+339,497
| +6% | +$37.8M | 0.78% | 11 |
|
|
2016
Q3 | $622M | Buy |
5,948,205
+268,968
| +5% | +$29.1M | 0.68% | 14 |
|
|
2016
Q2 | $560M | Buy |
5,679,237
+488,176
| +9% | +$50.5M | 0.64% | 20 |
|
|
2016
Q1 | $520M | Buy |
5,191,061
+190,009
| +4% | +$19.6M | 0.61% | 25 |
|
|
2015
Q4 | $599M | Sell |
5,001,052
-499,123
| -9% | -$57.7M | 0.7% | 19 |
|
|
2015
Q3 | $595M | Buy |
5,500,175
+74,069
| +1% | +$9.19M | 0.73% | 13 |
|
|
2015
Q2 | $628M | Buy |
5,426,106
+314,187
| +6% | +$35.9M | 0.71% | 15 |
|
|
2015
Q1 | $589M | Buy |
5,111,919
+698,507
| +16% | +$83.5M | 0.66% | 17 |
|
|
2014
Q4 | $494M | Sell |
4,413,412
-76,678
| -2% | -$8.09M | 0.56% | 31 |
|
|
2014
Q3 | $426M | Buy |
4,490,090
+566,860
| +14% | +$51.2M | 0.5% | 40 |
|
|
2014
Q2 | $337M | Buy |
3,923,230
+265,830
| +7% | +$20.2M | 0.38% | 63 |
|
|
2014
Q1 | $255M | Sell |
3,657,400
-141,208
| -4% | -$11.2M | 0.3% | 90 |
|
|
2013
Q4 | $321M | Sell |
3,798,608
-897,556
| -19% | -$71M | 0.38% | 58 |
|
|
2013
Q3 | $361M | Buy |
4,696,164
+244,210
| +5% | +$17.1M | 0.45% | 47 |
|
|
2013
Q2 | $260M | Buy |
+4,451,954
| New | +$268M | 0.34% | 74 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
American Century Companies's CELG Position: Q4 2019 in Review
American Century Companies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,275,067 shares — an estimated $127M sold.
American Century Companies first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $947M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- American Century Companies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- American Century Companies sold 1,275,067 Celgene Corp shares in Q4 2019, an estimated $127M.
- American Century Companies first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- American Century Companies's Celgene Corp position peaked at $947M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.